CD4 and tuberculosis: In 2019, the WHO expanded its recommendations for AlereLAM use for TB diagnosis—for inpatient PWH, the WHO strongly recommends AlereLAM for those with signs and symptoms of TB, those with advanced HIV disease or who are seriously ill, and those with a CD4 count of less than 200 cells/μL, irrespective of signs and symptoms [24].